and Stereoselective Allylindation of Alkynes Using InBr3 and Allylic

0 downloads 0 Views 955KB Size Report
Regio- and Stereoselective Allylindation of Alkynes Using InBr3 and Allylic. Silanes: Synthesis, Characterization, and Application of 1,4-Dienylindiums.
Supporting Information Regio- and Stereoselective Allylindation of Alkynes Using InBr3 and Allylic Silanes: Synthesis, Characterization, and Application of 1,4-Dienylindiums toward Skipped Dienes Yoshihiro Nishimoto1,*, Yi Junyi2, Tatsuaki Takata2, Akio Baba2, and Makoto Yasuda2,* 1 Frontier Research Base for Global Young Researchers Center for Open Innovation Research and Education (COiRE), Graduate School of Engineering, Osaka University 2 Department of Applied Chemistry, Graduate School of Engineering, Osaka University

Contents NOE Experiments ...............................................................................................................................2 NMR Spectra .......................................................................................................................................4

S1

NOE Experiments 1,4-dienylindium 3ha

S2

(Z)-(1-iodo-4-methylpenta-1,4-dien-2-yl)benzene (4ha)

S3

7 6 5 4 3

S4 45.82 36.44 31.87 29.43 29.38 29.22 26.99 22.67 21.78 14.13

13

8

77.32 77.00 76.68 76.19

9 2 3.40

3.02

2.05

2.02

1.05 1.08

1.00

5.92 4.83 4.75 4.33 2.87 2.18 2.16 2.14 1.65 1.43 1.42 1.41 1.39 1.38 1.36 1.33 1.30 14.0 1.29 1.28 1.25 1.23 0.90 0.88 0.87

1

113.03

149.37 142.45

NMR Spectra

(E)‐4‐(iodomethylene)‐2‐methyldodec‐1‐ene (4aa) 

H NMR (400 MHz, in CDCl3)

PPM

1 0

190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 -1

C NMR (100 MHz, in CDCl3)

PPM

0 -10

170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10

0

PPM 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10

PPM

HMQC

8 7

7

6 5

6 5

4

4

 

S5

3

3

2

2

1 PPM

HMBC  

1 PPM

 

(E)‐4‐(iodomethylene)‐2,7‐dimethyloct‐1‐ene (4ba) 

1

H NMR (400 MHz, in CDCl3)

13

C NMR (100 MHz, in CDCl3)

S6

(E)‐4‐(iodomethylene)‐2,6‐dimethylhept‐1‐ene (4ca) 

2.04 1.01 3.04

1.00

1.04 1.00

2.02

6.05

2.87 2.10 2.08 1.95 1.94 1.92 1.90 1.88 1.87 1.85 1.65 0.94 0.92

4.84 4.74

H NMR (400 MHz, in CDCl3) 6.01

1

7

6

5

4

3

2

1

0

-1

77.49 77.32 77.00 76.68

113.15

C NMR (100 MHz, in CDCl3) 148.39 142.43

13

8

26.84 22.38 21.77

9

46.12 44.66

PPM

PPM 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10

S7

0 -10

7 6 5 4 3

S8 47.33 42.06 29.93 26.29 26.01 21.96

13

8

77.32 77.00 76.68 76.04

9

113.68

2 1.02

2.00

2.00 0.92

1.01 1.01

0.97

4.06

6.02

1

142.82

151.77

5.83 4.87 4.77 2.81 2.62 2.60 2.59 2.59 2.57 2.56 1.79 1.78 1.75 1.70 1.67 1.61 1.60 1.57 1.36 1.36 1.32 1.29 1.27 1.26 1.23 1.23 1.19 1.18 1.16 1.15 1.14 1.13 1.12

(Z)‐(1‐iodo‐4‐methylpenta‐1,4‐dien‐2‐yl)cyclohexane (4da) 

H NMR (400 MHz, in CDCl3)

PPM

1 0

C NMR (400 MHz, in CDCl3)

PPM

190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10

0 -10

(E)‐(3‐(iodomethylene)‐5‐methylhex‐5‐en‐1‐yl)benzene (4fa) 

1

H NMR (400 MHz, in CDCl3)

13

C NMR (100 MHz, in CDCl3)

   

S9

(E)‐7‐chloro‐4‐(iodomethylene)‐2‐methylhept‐1‐ene (4ga) 

1

H NMR (400 MHz, CDCl3)

13

C NMR (100 MHz, CDCl3)

S10

170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10

0

PPM 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10

PPM

HMQC

8

HMBC

PPM

7 6 5 4 3 2 1 PPM

7 6 5 4 3 2 1

S11

(Z)‐(1‐iodo‐4‐methylpenta‐1,4‐dien‐2‐yl)benzene (4ha) 

1

H NMR (400 MHz, in CDCl3)

13

C NMR (100 MHz, in CDCl3)

S12

170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10

0

PPM 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10

PPM

HMQC

8 7

7

6 5

6 5

4

4

 

S13

3

3

2

2

1 PPM

HMBC   

1 PPM

 

(Z)‐(1‐iodopenta‐1,4‐dien‐2‐yl)benzene (4hb)  I

1 2

1

3

4 5

H NMR (400 MHz, in CDCl3)

13

C NMR (100 MHz, in CDCl3)

S14

(Z)‐1‐iodo‐2,4‐diphenylpenta‐1,4‐diene (4hc) 

1

 

H NMR (400 MHz, in CDCl3)

13

C NMR (100 MHz, in CDCl3)

S15

(Z)‐(1‐iodo‐3,3‐dimethylpenta‐1,4‐dien‐2‐yl)benzene (4hd)  I 1 2

3

4 5

  1

H NMR (400 MHz, CDCl3)

13

C NMR (100 MHz, CDCl3)

S16

(Z)‐1‐iodo‐2,3‐diphenylpenta‐1,4‐diene (4he) 

1

 

H NMR (400 MHz, in CDCl3)

13

C NMR (100 MHz, in CDCl3)

S17

(Z)‐(4‐methyl‐2‐phenylpenta‐1,4‐dien‐1‐yl)indium(III) bromide (3ha) 

1

 

H NMR (400 MHz, in CDCl3)

13

C NMR (100 MHz, in CDCl3)

S18

170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10

0

PPM 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10

PPM

HMQC

8

HMBC

PPM

7 6 5 4 3 2 1 PPM

7 6 5 4 3 2 1

S19

(Z)‐4‐methy‐1,2‐diphenylpenta‐1,4‐diene (5) 

1 2 3

1

4

5

H NMR (400 MHz, in CDCl3)

13

C NMR (100 MHz, in CDCl3)

S20

S21